Dr. Gomella on Current Perspectives on Prostate Cancer Screening

Video

Leonard Gomella, MD, physician, professor, and chair of the Department of Urology at Thomas Jefferson University and director of the Kimmel Cancer Center Network, discusses the current perspectives on screening for prostate cancer.

Leonard Gomella, MD, physician, professor, and chair of the Department of Urology at Thomas Jefferson University and director of the Kimmel Cancer Center Network, discusses the current perspectives on screening for prostate cancer.

Controversy remains on screening for prostate cancer, as the United States Preventative Services Task Force advises that men should not be screened. Gomella says that although practitioners see a positive impact on men who screen for the disease, they regularly fend off criticism that screening leads to overtreatment and overdiagnosis.

Therefore, he advises that screening efforts should be focused on younger, healthier men. Other factors to take into consideration include life expectancy and overall health of patients. Furthermore, Gomella adds, screening for prostate cancer has led to decreases in mortality and in metastatic disease.

Related Videos
Rita Nanda, MD
Vikram Narayan, MD
Daniel Olson, MD
Vishal Patel, MD, FAAD, FACMS, associate professor, Dermatology, George Washington (GW) School of Medicine & Health Sciences
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS